Molecular Cytogenetics Market Valued at $1.97 Billion by 2019: Transparency Market Research

Albany, NY, Oct. 17, 2014 (GLOBE NEWSWIRE) -- The global cytogenetics market will be valued at US$1.9 billion in the year 2019, after growth at a CAGR of 23.4% from 2013 to 2019, according to the report by Transparency Market Research. The market was worth US$468.2 million in 2012.

The research report titled "Molecular Cytogenetics Market (Technologies: FISH and aCGH; Applications: Genetic Disorders, Cancer and Personalized Medicine) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019", is aimed at establishing the importance of the upcoming technologies in molecular cytogenetics, namely FISH and aCGH.

Browse the full Molecular Cytogenetics Market report:

The report states that the array Comparative Genomic Hybridization (aCGH) market is expected to be a fast-growing sector, registering a CAGR of 20%. aCGH is a technique that utilizes a high resolution tool incorporating thousands of experiments in one array. This means that clinicians can shift from sequential diagnosis to parallel diagnosis, allowing them to conduct experiments with accurate results at one time.

For further inquiries, click here:

The report explains that Fluorescence In Situ Hybridization (FISH) technology is attributed to interpret information at the genome level, and currently dominates the molecular cytogenetics market. Over the past decade, the FISH technology has been used to identify various diseases as well as suggest accurate treatment. The technique is being constantly improved by work in the field of bioinformatics and genomics.

According to the report, aCGH is a more accurate technique, and is expected to surpass FISH in the next few years. The increase in demand for a better cytogenetic technique should be successfully met by expansions in manufacturer product portfolios.

Related report by Transparency Market Research:

The report also provides an exhaustive and comparative analysis of the key players in the industry: Agilent Technologies, Inc., Abbott Laboratories, Affymetrix, Inc., Bio-Rad Laboratories, BI Biological Industries, Illumina, Inc., Cytognomix, Inc., CytoTest, Inc., Inc., Hoffmann-La Roche Ltd., Life Technologies Corporation, LEICA BIOSYSTEMS, PerkinElmer, Inc., Oxford Gene Technology, Applied Spectral Imaging, Inc., and SciGene Corporation.

The report predominantly explores the molecular cytogenetics market using three categorical segregations. On the basis of technology, the report analyzes FISH and aCGH. The various applications documented in the report include cancer, genetic disorders, personalized medicines, and others. By geography, the report focuses on North America, Europe, Asia-Pacific, and Rest of the World.

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

CONTACT: Sheela AK State Tower, 90 State Street, Suite 700, Albany NY - 12207 USA/Canada Toll Free: 866-552-3453 Email: Web: Blog:

Source:Transparency Market Research